Olaf Determann

Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group

Olaf Determann, Eva Hoster, German Ott et al. · Blood · 2007 · 239 citations · Full text

Medicine, Oncology, Pathology +15

Ki-67 as a prognostic marker in mantle cell lymphoma—consensus guidelines of the pathology panel of the European MCL Network

Eva Hoster, Olaf Determann, Ilske Oschlies et al. · Journal of Hematopathology · 2009 · 173 citations · Full text

Veterinary Medicine, Oncology, Pathology +11

Tumor Sclerosis but Not Cell Proliferation or Malignancy Grade Is a Prognostic Marker in Advanced-Stage Follicular Lymphoma: The German Low Grade Lymphoma Study Group

Eva Hoster, Lars Rölver, Carsten Schrader et al. · Journal of Clinical Oncology · 2007 · 67 citations · Full text

Medicine, Oncology, Pathology +17

Secondary Neoplasms Subsequent to Berlin-Frankfurt-Muenster (BFM) Therapy of Non-Hodgkin Lymphoma of Childhood: Significantly Higher Risk for Patients with Lymphoblastic Lymphoma Compared to Other NHL-Subtypes.

Olga Wachowski, Martin Zimmermann, Birgit Burkhardt et al. · Blood · 2005 · 10 citations

Medicine, Oncology, Pediatrics +12